[go: up one dir, main page]

BG106728A - Chemical methods and intermediate compounds - Google Patents

Chemical methods and intermediate compounds

Info

Publication number
BG106728A
BG106728A BG106728A BG10672802A BG106728A BG 106728 A BG106728 A BG 106728A BG 106728 A BG106728 A BG 106728A BG 10672802 A BG10672802 A BG 10672802A BG 106728 A BG106728 A BG 106728A
Authority
BG
Bulgaria
Prior art keywords
chemical methods
preparation
intermediate compounds
intermediates
relates
Prior art date
Application number
BG106728A
Other languages
Bulgarian (bg)
English (en)
Inventor
Michael Gravestock
Kenneth Warren
David Ennis
Angela CURRIE
Debra Ainge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of BG106728A publication Critical patent/BG106728A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
BG106728A 1999-12-03 2002-05-20 Chemical methods and intermediate compounds BG106728A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates
PCT/GB2000/004527 WO2001040236A2 (en) 1999-12-03 2000-11-28 Phosphorylation of terminal primary alcohol groups

Publications (1)

Publication Number Publication Date
BG106728A true BG106728A (en) 2003-02-28

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
BG106728A BG106728A (en) 1999-12-03 2002-05-20 Chemical methods and intermediate compounds

Country Status (22)

Country Link
EP (1) EP1237895A2 (xx)
JP (1) JP2003515539A (xx)
KR (1) KR20020058072A (xx)
CN (1) CN1433421A (xx)
AR (1) AR026700A1 (xx)
AU (1) AU762241B2 (xx)
BG (1) BG106728A (xx)
BR (1) BR0016087A (xx)
CA (1) CA2395052A1 (xx)
CO (1) CO5271712A1 (xx)
CZ (1) CZ20021912A3 (xx)
EE (1) EE200200282A (xx)
GB (1) GB9928499D0 (xx)
HU (1) HUP0204052A2 (xx)
IL (1) IL149641A0 (xx)
IS (1) IS6401A (xx)
MX (1) MXPA02005396A (xx)
NO (1) NO20022605L (xx)
PL (1) PL364762A1 (xx)
SK (1) SK7862002A3 (xx)
WO (1) WO2001040236A2 (xx)
ZA (1) ZA200203876B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
EP1427711B1 (en) 2001-09-11 2005-07-13 AstraZeneca AB Oxazolidinone and/or isoxazoline derivatives as antibacterial agents
WO2003035073A1 (en) 2001-10-25 2003-05-01 Astrazeneca Ab Isoxazoline derivatives useful as antimicrobials
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AU2003207340A1 (en) 2002-02-28 2003-09-09 Astrazeneca Ab 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents
BR0308018A (pt) 2002-02-28 2005-01-04 Astrazeneca Ab Composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo, pró-droga, método para produzir um efeito antibacteriano em um animal de sangue quente, uso de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hirolisável in vivo, composição farmacêutica, e, processo para a preparação de um composto ou um seu sal farmaceuticamente aceitável ou um seu éster hidrolisável in vivo
DE60304360T2 (de) 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
AR042086A1 (es) 2002-11-21 2005-06-08 Upjohn Co N-aril-2- oxazolidinon -5- carboxamidas y sus derivados, usados como agentes antibacterianos
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
AR045690A1 (es) 2003-06-03 2005-11-09 Rib X Pharmaceuticals Inc Compuestos biaril heterociclicos y metodos para preparar y utilizar los mismos
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
EP1713785A1 (en) 2003-12-17 2006-10-25 Rib-X Pharmaceuticals, Inc. Halogenated biaryl heterocyclic compounds and methods of making and using the same
WO2005085266A2 (en) 2004-02-27 2005-09-15 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
US8399660B2 (en) 2005-06-08 2013-03-19 Rib-X Pharmaceuticals, Inc. Process for the synthesis of triazoles
JP5259600B2 (ja) 2006-09-25 2013-08-07 ウォックハート リサーチ センター 置換ピペリジノフェニルオキサゾリジノン
US9572809B2 (en) 2012-07-18 2017-02-21 Spero Trinem, Inc. Combination therapy to treat Mycobacterium diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010052615A (ko) * 1998-06-05 2001-06-25 다비드 에 질레스 옥사졸리디논 유도체, 이것의 제조 방법 및 이것을함유하는 약학 조성물

Also Published As

Publication number Publication date
PL364762A1 (en) 2004-12-13
CN1433421A (zh) 2003-07-30
CA2395052A1 (en) 2001-06-07
KR20020058072A (ko) 2002-07-12
EE200200282A (et) 2003-06-16
AU762241B2 (en) 2003-06-19
WO2001040236A3 (en) 2002-05-10
EP1237895A2 (en) 2002-09-11
WO2001040236A2 (en) 2001-06-07
CZ20021912A3 (cs) 2002-08-14
NO20022605L (no) 2002-06-26
IL149641A0 (en) 2002-11-10
BR0016087A (pt) 2002-08-06
AR026700A1 (es) 2003-02-26
ZA200203876B (en) 2003-08-15
AU1715601A (en) 2001-06-12
CO5271712A1 (es) 2003-04-30
MXPA02005396A (es) 2002-11-29
HUP0204052A2 (hu) 2003-03-28
JP2003515539A (ja) 2003-05-07
GB9928499D0 (en) 2000-02-02
IS6401A (is) 2002-05-28
SK7862002A3 (en) 2003-02-04
NO20022605D0 (no) 2002-05-31

Similar Documents

Publication Publication Date Title
BG106728A (en) Chemical methods and intermediate compounds
BG103485A (en) Ketobanzamides as calpain inhibitors
AU698620B2 (en) Hydrophilated dental impression compounds
MX9702865A (es) Agentes estrogenicos.
DE69534300D1 (de) Neues multimerisierendes reagenz
BR0109922A (pt) Compostos quìmicos
DE60112609D1 (en) Pyrazolopyridine
MXPA02012271A (es) Nuevos compuestos que poseen actividad antibacteriana, antifungal o antitumor.
EA200300580A1 (ru) Соединения лактама
DE69739853D1 (de) Synthetische rapamycinderivate als multimerisierende wirkstoffe für chimere proteine mit von immunophilin abgeleiteten domänen
BG106340A (en) Substituted oxoazaheterocyclyl compounds
PL366198A1 (en) Novel compounds
DE60112330D1 (en) Pyrazolopyridinderivate
DE60236528D1 (de) Schwach gefärbte natriumarme benzoxazinon-uv-absorber und verfahren zu ihrer herstellung
SE9904108D0 (sv) Nya föreningar
BG105009A (en) Method for producing 4-carboxyamino-2-substituted 1,2,3,4-tetrahydroquinoline
DE602004005323D1 (de) Azidfreies verfahren zur herstellung von 1,2-diaminoverbindungen
PL373377A1 (en) Furancarboxamides
TWI319316B (en) Aminoalcohol derivatives and pharmaceutical compositions containing the same
EP1181925A3 (en) Protection of keratinous fibers using ceramides and/or glycoceramides
MXPA02012426A (es) Compuestos nuevos.
PL373468A1 (en) Oxathiincarboxamides
ATE252589T1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
SE9904128D0 (sv) Novel compounds
MXPA04005151A (es) Compuestos terapeuticos.